525 related articles for article (PubMed ID: 17634972)
41. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
Ogungbenro K; Aarons L
J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
[TBL] [Abstract][Full Text] [Related]
42. Group sequential and discretized sample size re-estimation designs: a comparison of flexibility.
Wu X; Cui L
Stat Med; 2012 Oct; 31(24):2844-57. PubMed ID: 22733405
[TBL] [Abstract][Full Text] [Related]
43. Adaptive design method based on sum of p-values.
Chang M
Stat Med; 2007 Jun; 26(14):2772-84. PubMed ID: 17133651
[TBL] [Abstract][Full Text] [Related]
44. Group sequential t-test for clinical trials with small sample sizes across stages.
Shao J; Feng H
Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
[TBL] [Abstract][Full Text] [Related]
45. Adaptive designs for confirmatory clinical trials.
Bretz F; Koenig F; Brannath W; Glimm E; Posch M
Stat Med; 2009 Apr; 28(8):1181-217. PubMed ID: 19206095
[TBL] [Abstract][Full Text] [Related]
46. Sample size for testing difference between two proportions for the bilateral-sample design.
Qiu SF; Tang NS; Tang ML; Pei YB
J Biopharm Stat; 2009 Sep; 19(5):857-71. PubMed ID: 20183448
[TBL] [Abstract][Full Text] [Related]
47. The advantages and disadvantages of adaptive designs for clinical trials.
Bauer P; Brannath W
Drug Discov Today; 2004 Apr; 9(8):351-7. PubMed ID: 15081962
[TBL] [Abstract][Full Text] [Related]
48. Assessment of the Gould-Shih procedure for sample size re-estimation.
Waksman JA
Pharm Stat; 2007; 6(1):53-65. PubMed ID: 17133631
[TBL] [Abstract][Full Text] [Related]
49. A free gift: an adaptive strategy in a single-arm trial using an exact test through the binomial distribution.
Wang J
J Biopharm Stat; 2012; 22(6):1127-36. PubMed ID: 23075012
[TBL] [Abstract][Full Text] [Related]
50. Sample size determination for comparing several survival curves with unequal allocations.
Halabi S; Singh B
Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
[TBL] [Abstract][Full Text] [Related]
51. Robustness of an odds-ratio test in a stratified group sequential trial with a binary outcome measure.
Srivastava DK; Rai SN; Pan J
Biom J; 2007 Jun; 49(3):351-64. PubMed ID: 17623341
[TBL] [Abstract][Full Text] [Related]
52. Optimal spending functions for asymmetric group sequential designs.
Anderson KM
Biom J; 2007 Jun; 49(3):337-45. PubMed ID: 17623339
[TBL] [Abstract][Full Text] [Related]
53. Information-based monitoring of clinical trials.
Tsiatis AA
Stat Med; 2006 Oct; 25(19):3236-44; discussion 3320-5, 3326-47. PubMed ID: 16927248
[TBL] [Abstract][Full Text] [Related]
54. Power and sample size when multiple endpoints are considered.
Senn S; Bretz F
Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
[TBL] [Abstract][Full Text] [Related]
55. Variance estimation in clinical studies with interim sample size re-estimation.
Miller F
Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
[TBL] [Abstract][Full Text] [Related]
56. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
Morgan CC; Stephen Coad D
Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
[TBL] [Abstract][Full Text] [Related]
57. Innovative approaches to clinical development and trial design.
Orloff JJ; Stanski D
Ann Ist Super Sanita; 2011; 47(1):8-13. PubMed ID: 21430331
[TBL] [Abstract][Full Text] [Related]
58. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
Lai TL; Shih MC; Zhu G
Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
[TBL] [Abstract][Full Text] [Related]
59. Tests for inter-subject and total variabilities under crossover designs.
Lee Y; Shao J; Chow SC; Wang H
J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
[TBL] [Abstract][Full Text] [Related]
60. Sample size determination for clinical trials in patients with nonlinear disease progression.
Yan X; Su X
J Biopharm Stat; 2006; 16(1):91-105. PubMed ID: 16440839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
